New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology

MD Giraldez, D Carneros, C Garbers… - Nature reviews …, 2021 - nature.com
IL-6 family cytokines are defined by the common use of the signal-transducing receptor
chain glycoprotein 130 (gp130). Increasing evidence indicates that these cytokines are …

Structural understanding of interleukin 6 family cytokine signaling and targeted therapies: focus on interleukin 11

RD Metcalfe, TL Putoczki, MDW Griffin - Frontiers in immunology, 2020 - frontiersin.org
Cytokines are small signaling proteins that have central roles in inflammation and cell
survival. In the half-century since the discovery of the first cytokines, the interferons, over fifty …

A myeloid–stromal niche and gp130 rescue in NOD2-driven Crohn's disease

S Nayar, JK Morrison, M Giri, K Gettler, L Chuang… - Nature, 2021 - nature.com
Crohn's disease is a chronic inflammatory intestinal disease that is frequently accompanied
by aberrant healing and stricturing complications. Crosstalk between activated myeloid and …

Vanillin-based indolin-2-one derivative bearing a pyridyl moiety as a promising anti-breast cancer agent via anti-estrogenic activity

O Bender, I Celik, R Dogan, A Atalay, ME Shoman… - ACS …, 2023 - ACS Publications
The structure-based design introduced indoles as an essential motif in designing new
selective estrogen receptor modulators employed for treating breast cancer. Therefore, here …

STAT3 signaling in breast cancer: multicellular actions and therapeutic potential

SQ To, RS Dmello, AK Richards, M Ernst, AL Chand - Cancers, 2022 - mdpi.com
Simple Summary Many signaling pathways are overactive in breast cancer, and among
them is the STAT3 signaling pathway. STAT3 is activated by secreted factors within the …

Repurposing of drugs as STAT3 inhibitors for cancer therapy

PS Thilakasiri, RS Dmello, TL Nero, MW Parker… - Seminars in cancer …, 2021 - Elsevier
Drug repurposing is a valuable approach in delivering new cancer therapeutics rapidly into
the clinic. Existing safety and patient tolerability data for drugs already in clinical use …

Combination of bazedoxifene with chemotherapy and SMAC-mimetics for the treatment of colorectal cancer

RS Dmello, M Palmieri, PS Thilakasiri, L Doughty… - Cell Death & …, 2024 - nature.com
Excessive STAT3 signalling via gp130, the shared receptor subunit for IL-6 and IL-11,
contributes to disease progression and poor survival outcomes in patients with colorectal …

SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling

BD López-Ayllón, A de Lucas-Rius… - Frontiers in …, 2023 - frontiersin.org
SARS-CoV-2, the cause of the COVID-19 pandemic, possesses eleven accessory proteins
encoded in its genome. Their roles during infection are still not completely understood. In …

Local and systemic effects of interleukin‐6 (IL‐6) in inflammation and cancer

S Rose‐John - FEBS letters, 2022 - Wiley Online Library
Interleukin‐6 (IL‐6) is an inflammatory cytokine, the level of which is highly elevated in most,
if not all, inflammatory states. IL‐6 triggers cell type‐specific responses and acts on target …

Interleukin-11 and its eminent role in tissue fibrosis: a possible therapeutic target

S O'Reilly - Clinical and Experimental Immunology, 2023 - academic.oup.com
Interleukin-11 is a cytokine from the IL-6 family of cytokines that includes IL-6 and oncostatin-
M. Initially described for its role in platelet generation, it is now appreciated that this cytokine …